News
Important Only
Other
BRIEF-Primaris REIT Announces Successful $200 Million Unsecured Debenture Offering
Feb 19 (Reuters) - Primaris Real Estate Investment Trust PMZ_u.TO:PRIMARIS REIT ANNOUNCES SUCCESSFUL $200 MILLION UNSECURED DEBENTURE OFFERINGSource text: ID:nBw6KJKzzaFurther company coverage: [PMZ_u.TO]Reuters
Feb 19, 2025
Other
BRIEF-Clarity Receives Us FDA Fast Track Designation For The Treatment Of Metastatic Castration-Resistant Prostate Cancer Patients With Cu-67 Sar-Bispsma
Feb 19 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX:CLARITY RECEIVES US FDA FAST TRACK DESIGNATION FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH CU-67 SAR-BISPSMASource text: ID:nPn29BQ1saFurther company coverage: CU6.AXReuters
Feb 19, 2025
Other
BRIEF-Nisun International Partners With Gold Of China To Expand Gold Business, Targeting $30-$50 Million In Sales Growth From Venture In 2025
Feb 19 (Reuters) - Nisun International Enterprise Development Group Co Ltd NISN.O:NISUN INTERNATIONAL PARTNERS WITH GOLD OF CHINA TO EXPAND GOLD BUSINESS, TARGETING $30-$50 MILLION IN SALES GROWTH FROM VENTURE IN 2025Source text: ID:nPn6fhg61aFurther company coverage: NISN.OReuters
Feb 19, 2025
Other
BRIEF-First Quantum Minerals Announces Cash Tender Offer To Purchase Its Outstanding 6.875% Senior Notes Due 2027 In A Maximum Aggregate Principal Amount Of Up To $500,000,000
Feb 19 (Reuters) - First Quantum Minerals Ltd FM.TO:FIRST QUANTUM MINERALS ANNOUNCES CASH TENDER OFFER TO PURCHASE ITS OUTSTANDING 6.875% SENIOR NOTES DUE 2027 IN A MAXIMUM AGGREGATE PRINCIPAL AMOUNT OF UP TO $500,000,000Source text: ID:nPn4XKNKnaFurther company coverage: FM.TOReuters
Feb 19, 2025
Other
BRIEF-Vertafore Report Shows How Carrier Processes, Communication And Technology Impact The Agent Experience
Feb 19 (Reuters) - Vertafore VTFOR.UL :VERTAFORE REPORT SHOWS HOW CARRIER PROCESSES, COMMUNICATION AND TECHNOLOGY IMPACT THE AGENT EXPERIENCESource text: ID:nPn66hgqlaFurther company coverage: VTFOR.ULReuters
Feb 19, 2025
Other
BRIEF-UK's CMA Says GXO-Wincanton Deal Could Reduce Competition
Feb 19 (Reuters) - UK's CMA:MERGER UPDATE: GXO / WINCANTONGXO'S PURCHASE OF WINCANTON LIKELY TO REDUCE COMPETITION IN SUPPLY OF DEDICATED WAREHOUSING SERVICES TO GROCERY CUSTOMERS IN UKSource text: ID:nRSS7218XaFurther company coverage: GXO.NReuters
Feb 19, 2025
Stocks
BUZZ-Insurer Unum ticks up on $1 billion share repurchase authorization
** Shares of insurer Unum Group UNM.N rise ~1% to $74.72 in early trading** UNM late Tuesday announced its board had authorized repurchase of up to $1 billion of its common stock from time to time beginning on April 1** Co's board also authorize the termination of UNM's current share repurch...Reuters
Feb 19, 2025
Other
Colombia's Grupo Aval forecasts double-digit profitability in 2025
Feb 19 (Reuters) - Colombian financial conglomerate Grupo Aval GAA.CN expects to reach double-digit growth in profitability in 2025, an executive said on Wednesday during a call to present their results. On Tuesday afternoon Aval posted a more than three-fold increase in its net profit in the fourth...Reuters
Feb 19, 2025
Stocks
BUZZ-Workday slips on Morgan Stanley downgrade
** Human resources software provider Workday WDAY.O down 3.5% at $256.31 in morning trading** Morgan Stanley downgrades co to "equal weight" from "overweight", and trims PT to $275 from $330** Brokerage says "recent investments in distribution have failed to catalyze topline grow...Reuters
Feb 19, 2025
Other
BRIEF-Alto Neuroscience Announces U.S. Patent Granted Covering Alto-300 As A Treatment For Patients With Major Depressive Disorder Characterized By An Electroencephalogram Biomarker
Feb 19 (Reuters) - Alto Neuroscience Inc ANRO.N:ALTO NEUROSCIENCE ANNOUNCES U.S. PATENT GRANTED COVERING ALTO-300 AS A TREATMENT FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER CHARACTERIZED BY AN ELECTROENCEPHALOGRAM BIOMARKERSource text: ID:nBw56gCPnaFurther company coverage: ANRO.NReuters
Feb 19, 2025
Other
Herc to buy H&E for $3.83 billion after rival United Rentals exits deal
Feb 19 (Reuters) - Machinery rentals firm Herc Holdings HRI.N has signed a deal to buy H&E Equipment Services HEES.O for $3.83 billion, excluding debt, after H&E terminated its merger agreement with United Rentals URI.N, the companies said on Wednesday.The cash and stock deal will combine th...Reuters
Feb 19, 2025
Other
BRIEF-Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital
Feb 19 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ANNOUNCES COMPLETION OF A NOVEL HEAD COIL BY TESLA FOR MEASURING BRAIN STRUCTURE LITHIUM LEVELS IN FIVE UPCOMING PHASE II CLINICAL TRIALS AT MASSACHUSETTS GENERAL HOSPITALSource text: ID:nBw3YrfS7aFurther company coverage: ALZN.OReuters
Feb 19, 2025
Other
BRIEF-Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Feb 19 (Reuters) - Twist Bioscience Corp TWST.O:TWIST BIOSCIENCE CORPORATION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw2m9mWZaFurther company coverage: TWST.OReuters
Feb 19, 2025
Other
BRIEF-Ontrak Health And Sentara Health Plans Execute Three-Year Contract Extension Following Several Expansions
Feb 19 (Reuters) - Ontrak Inc OTRK.O:ONTRAK HEALTH AND SENTARA HEALTH PLANS EXECUTE THREE-YEAR CONTRACT EXTENSION FOLLOWING SEVERAL EXPANSIONSONTRAK INC - EXTENDS PARTNERSHIP WITH SENTARA HEALTH PLANS THROUGH DECEMBER 2027Source text: ID:nBw6chb4taFurther company coverage: OTRK.OReuters
Feb 19, 2025
Other
BRIEF-Branchout Food Welcomes Jesse Thomas As Chief Brand Officer To Drive Direct-To-Consumer And Brand Strategy
Feb 19 (Reuters) - BranchOut Food Inc BOF.O:BRANCHOUT FOOD WELCOMES JESSE THOMAS AS CHIEF BRAND OFFICER TO DRIVE DIRECT-TO-CONSUMER AND BRAND STRATEGYSource text: ID:nGNX38x74sFurther company coverage: BOF.OReuters
Feb 19, 2025
Other
BRIEF-NKGen Appoints Dr. Anita Fletcher As National Principal Investigator For Phase 2A Troculeucel Trial Evaluating Moderate Alzheimer’S Disease With Adventhealth Orlando As First East Coast Site
Feb 19 (Reuters) - Nkgen Biotech Inc NKGN.O:NKGEN APPOINTS DR. ANITA FLETCHER AS NATIONAL PRINCIPAL INVESTIGATOR FOR PHASE 2A TROCULEUCEL TRIAL EVALUATING MODERATE ALZHEIMER’S DISEASE WITH ADVENTHEALTH ORLANDO AS FIRST EAST COAST SITESource text: ID:nGNX9pTy5bFurther company coverage: NKGN.OReuters
Feb 19, 2025
Other
BRIEF-AskBio Receives FDA Regenerative Medicine Advanced Therapy Designation For Parkinson’S Disease Investigational Gene Therapy
Feb 19 (Reuters) - ASKBIO RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY DESIGNATION FOR PARKINSON’S DISEASE INVESTIGATIONAL GENE THERAPYSource text: ID:nGNX88bDLzReuters
Feb 19, 2025
